The global pharmaceutical membrane filtration market size was estimated to be USD 7.92 billion in 2023 and is expected to reach at USD 32.80 billion by 2034 with a CAGR of 13.79% during the forecast period 2024-2034. Surge in adoption of single-use technologies, increasing demand for ultrafiltration membranes, rising adoption of nanofiltration technologies, growing investment for research & development activities, surge in partnerships within market players, and increasing funding for the development of advanced filtration techniques are some of the key factors boosting the market growth.
Increasing funding for the development of advanced filtration techniques is predicted to boost the market growth during the forecast period. Membrane filtration has become a standard practice in the pharmaceutical industry and is utilized across various dosage forms. It is employed for separating solids from liquid suspensions containing particles of varying sizes, ranging from millimeters to nanometers. This application encompasses tasks like eliminating impurities from raw materials and clarifying product formulations before packaging. The pharmaceutical sector is experiencing a surge in demand for membrane filters because they can also serve downstream in the processing of dosage forms, such as the removal of particles during wet granulation preparations or final tablet compression stages. For instance, in August 2022, The University of Arkansas has been granted $6 million by the U.S. National Science Foundation (NSF). The purpose of the grant is to establish an efficient purification system and design specialized membranes for purifying upcoming virus particles and virus-like structures on a larger scale. This innovation aims to supplant conventional methods, expediting the manufacturing of viral vectors used in vaccine production.
By material, polyethersulfone was the highest revenue-grossing segment in the global pharmaceutical membrane filtration market in 2023 owing to the rising applications of polyethersulfone in dental & medical sector, increasing filtration needs in sanitary & pharmaceutical industries, and surge in launch of advanced products. For instance, in April 2023, Porvair Filtration Group has introduced the Biofil™ 3 and Biofil™ 3 Plus series of polyethersulfone items designed for the sterile filtration of liquids. Additionally, mixed cellulose ester & cellulose acetate (MCE & CA) is predicted to grow at fastest CAGR during the forecast period owing to the surge in adoption of various types of membrane filters for different filtration applications in the biopharmaceutical manufacturing industry.
By technique, microfiltration was the highest revenue-grossing segment in the global pharmaceutical membrane filtration market in 2023 owing to rising demand in the cold sterilization of pharmaceuticals, surge in pharmaceutical research & drug development, growing demand for good manufacturing practices (GMP) & single-use technologies in the pharmaceutical business due to their adaptability & efficiency gains, reduced operating costs, excellent performance, & usability, and increasing launch of advanced technology, and rising mergers & acquisitions within market players. For instance, in January 2022, SUEZ- Water Technologies & Solutions acquired Sentinel Monitoring Systems, a company specializing in real-time microbiological monitoring. Additionally, nanofiltration is predicted to grow at fastest CAGR during the forecast period owing to the ability to produce pharmaceuticals with improved quality and safety requirements at cheaper prices, surge in demand for precise biomolecule separation, growing emphasis on innovations makes it possible to manufacture drugs with higher quality and safety standards at lower costs, growing adoption of cutting-edge nanofiltration technologies, rapid adoption of nanofiltration integration into current pharmaceutical production processes.
By application, final product processing was the highest revenue-grossing segment in the global pharmaceutical membrane filtration market in 2023 owing to the rising generic drug manufacture, expanding biopharmaceutical sector, increasing adoption of membrane filters in sterile filtering, protein purification, & virus clearance procedures, surge in manufacturing of large molecules, and growing initiatives by leading market players. For instance, in July 2023, Renowned industry frontrunner Sartorius has introduced an advanced lineup of membrane filtration products that combine effectiveness with affordability. The upcoming releases from this German company are set to transform the sector with their state-of-the-art technology and improved efficiency. This strategic initiative by Sartorius is projected to set fresh benchmarks within the industry, furnishing pharmaceutical producers with upgraded filtration capabilities and decreased operational expenses. Additionally, cell separation is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of chronic and infectious diseases, growing research & development activities, and increasing focus on development of advanced biologics.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in development & improvement of healthcare systems, growing pharmaceutical research & development activities, increasing expenditure on healthcare, rising demand for membrane chromatography, surge in demand for advanced technologies & processes, and growing collaborations within market players. For instance, in January 2023, Sartorius AG, a company based in Germany, and RoosterBio Inc, headquartered in the United States, have entered into a partnership agreement. This collaboration aims to offer purification solutions and create comprehensive downstream manufacturing procedures for exosome-based therapies. As part of this collaboration, Sartorius AG will supply a range of filtration products designed for exosomes. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the low-cost of manufacturing benefit, surge in pharmaceutical research & development activities, growing technological advancements, and rising focus on expansion by major market players. For instance, in February 2022, According to a BioProcessing International article from 2022, China and India hold the second and third positions, respectively, in terms of pharmaceutical production capacities.
Increasing funding for the development of advanced filtration techniques is predicted to boost the market growth during the forecast period. Membrane filtration has become a standard practice in the pharmaceutical industry and is utilized across various dosage forms. It is employed for separating solids from liquid suspensions containing particles of varying sizes, ranging from millimeters to nanometers. This application encompasses tasks like eliminating impurities from raw materials and clarifying product formulations before packaging. The pharmaceutical sector is experiencing a surge in demand for membrane filters because they can also serve downstream in the processing of dosage forms, such as the removal of particles during wet granulation preparations or final tablet compression stages. For instance, in August 2022, The University of Arkansas has been granted $6 million by the U.S. National Science Foundation (NSF). The purpose of the grant is to establish an efficient purification system and design specialized membranes for purifying upcoming virus particles and virus-like structures on a larger scale. This innovation aims to supplant conventional methods, expediting the manufacturing of viral vectors used in vaccine production.
By material, polyethersulfone was the highest revenue-grossing segment in the global pharmaceutical membrane filtration market in 2023 owing to the rising applications of polyethersulfone in dental & medical sector, increasing filtration needs in sanitary & pharmaceutical industries, and surge in launch of advanced products. For instance, in April 2023, Porvair Filtration Group has introduced the Biofil™ 3 and Biofil™ 3 Plus series of polyethersulfone items designed for the sterile filtration of liquids. Additionally, mixed cellulose ester & cellulose acetate (MCE & CA) is predicted to grow at fastest CAGR during the forecast period owing to the surge in adoption of various types of membrane filters for different filtration applications in the biopharmaceutical manufacturing industry.
By technique, microfiltration was the highest revenue-grossing segment in the global pharmaceutical membrane filtration market in 2023 owing to rising demand in the cold sterilization of pharmaceuticals, surge in pharmaceutical research & drug development, growing demand for good manufacturing practices (GMP) & single-use technologies in the pharmaceutical business due to their adaptability & efficiency gains, reduced operating costs, excellent performance, & usability, and increasing launch of advanced technology, and rising mergers & acquisitions within market players. For instance, in January 2022, SUEZ- Water Technologies & Solutions acquired Sentinel Monitoring Systems, a company specializing in real-time microbiological monitoring. Additionally, nanofiltration is predicted to grow at fastest CAGR during the forecast period owing to the ability to produce pharmaceuticals with improved quality and safety requirements at cheaper prices, surge in demand for precise biomolecule separation, growing emphasis on innovations makes it possible to manufacture drugs with higher quality and safety standards at lower costs, growing adoption of cutting-edge nanofiltration technologies, rapid adoption of nanofiltration integration into current pharmaceutical production processes.
By application, final product processing was the highest revenue-grossing segment in the global pharmaceutical membrane filtration market in 2023 owing to the rising generic drug manufacture, expanding biopharmaceutical sector, increasing adoption of membrane filters in sterile filtering, protein purification, & virus clearance procedures, surge in manufacturing of large molecules, and growing initiatives by leading market players. For instance, in July 2023, Renowned industry frontrunner Sartorius has introduced an advanced lineup of membrane filtration products that combine effectiveness with affordability. The upcoming releases from this German company are set to transform the sector with their state-of-the-art technology and improved efficiency. This strategic initiative by Sartorius is projected to set fresh benchmarks within the industry, furnishing pharmaceutical producers with upgraded filtration capabilities and decreased operational expenses. Additionally, cell separation is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of chronic and infectious diseases, growing research & development activities, and increasing focus on development of advanced biologics.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in development & improvement of healthcare systems, growing pharmaceutical research & development activities, increasing expenditure on healthcare, rising demand for membrane chromatography, surge in demand for advanced technologies & processes, and growing collaborations within market players. For instance, in January 2023, Sartorius AG, a company based in Germany, and RoosterBio Inc, headquartered in the United States, have entered into a partnership agreement. This collaboration aims to offer purification solutions and create comprehensive downstream manufacturing procedures for exosome-based therapies. As part of this collaboration, Sartorius AG will supply a range of filtration products designed for exosomes. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the low-cost of manufacturing benefit, surge in pharmaceutical research & development activities, growing technological advancements, and rising focus on expansion by major market players. For instance, in February 2022, According to a BioProcessing International article from 2022, China and India hold the second and third positions, respectively, in terms of pharmaceutical production capacities.
Segmentation: Pharmaceutical Membrane Filtration Market Report 2022 - 2033
Pharmaceutical Membrane Filtration Market Analysis & Forecast by Material 2023 - 2034 (Revenue USD Bn)
- Polyethersulfone (PES)
- Mixed Cellulose Ester & Cellulose Acetate (MCE & CA)
- Polyvinylidene Difluoride (PVDF)
- Nylon Membrane Filters
- Others
Pharmaceutical Membrane Filtration Market Analysis & Forecast by Technique 2023 - 2034 (Revenue USD Bn)
- Microfiltration
- Ultrafiltration
- Nanofiltration
- Others
Pharmaceutical Membrane Filtration Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Final Product Processing
- Raw Material Filtration
- Cell Separation
- Water Purification
- Air Purification
Pharmaceutical Membrane Filtration Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Pharmaceutical Membrane Filtration Market: Material Estimates & Trend Analysis
8. Pharmaceutical Membrane Filtration Market: Technique Estimates & Trend Analysis
9. Pharmaceutical Membrane Filtration Market: Application Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Pharmaceutical Membrane Filtration Market
12. Europe Global Pharmaceutical Membrane Filtration Market
13. Asia Pacific Global Pharmaceutical Membrane Filtration Market
14. Latin America Global Pharmaceutical Membrane Filtration Market
15. MEA Global Pharmaceutical Membrane Filtration Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Merck Millipore
- Repligen Corporation
- 3M Company
- GE Healthcare
- Thermo Fisher Scientific
- GEA Group
- Danaher Corporation
- Sartorius Stedim Biotech
- Graver Technologies
- Parker Hannifin Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 7.92 Billion |
| Forecasted Market Value ( USD | $ 32.8 Billion |
| Compound Annual Growth Rate | 13.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
